首页> 外文期刊>Journal of Medical Radiation Sciences >Letter in response to “Cherry‐picking of evidence fails to accurately show extent of overdiagnosis: Mammographic screening harms understated”
【24h】

Letter in response to “Cherry‐picking of evidence fails to accurately show extent of overdiagnosis: Mammographic screening harms understated”

机译:回应“樱桃取证未能准确显示过度诊断的程度:低估了乳房X光检查的危害”的信函

获取原文
           

摘要

AbstractThe findings of the Independent Breast Screening Review (IBSR) by the Independent UK Panel on Breast Cancer Screening, led by Prof. Sir Michael Marmot, have been published subsequent to the review by Lee and Peters. The key findings of the IBSR “suggested a 20% reduction in mortality in women invited to participate in a 20-year screening programme” and that “1 breast cancer death was averted for every 235 women invited to screening and 1 death averted for every 180 women who attend screening.” This review cannot be accused of “cherry-picking” evidence with regard to mammographic screening. An editorial in Lancet, commenting on the IBSR, states that the review should begin to lay the benefits versus harm controversy to rest.
机译:摘要由迈克尔·马莫特爵士(Sir Michael Marmot)教授领导的英国独立乳腺癌筛查专家组的独立乳腺癌筛查评论(IBSR)的发现已在李和彼得斯的评论之后发表。 IBSR的主要发现“建议邀请参加20年筛查计划的女性的死亡率降低20%”,并且“每235名接受筛查的女性避免1例乳腺癌死亡,每180例转移1例死亡”参加筛查的女性。”不能因为乳房X光筛查的“樱桃采摘”证据而指责此评价。 《柳叶刀》杂志的一篇社论对IBSR进行了评论,该评论指出,审查应开始着眼于利弊论争。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号